The CBD Conundrum at the FDA

Should cannabidiol be regulated as a supplement, or a drug? Is it effective? Safe? Big business waits impatiently in the wings as the agency thinks through decisions to shape a multi-billion-dollar industry.

CBD
New York

New York’s Nail-Biter: Will “Zombie” Cannabis Legalization Bill Make It?

Today in Albany, the legislative session draws to a close.

Q&A

Q&A: How Clark University Hopes to Prepare Future Cannabis Regulators

“It is our responsibility to bring a legitimate and serious educational response to... an issue that is straining many municipalities, state agencies and police and other public safety officials.”

Q&A, Research

Q&A: Do Competing Cannabis Interests Repackage Opioid Research?

A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”